Bjorn Lomborg and the Long Con

on

Not to Be Missed: Mashey Bashing Bjorn

Frequent DeSmogBlog comment contributor John R. Mashey does a lovely job deconstructing Bjorn Lomborg‘s fictional liberalism in a post here at The Way Things Break.

Lomborg’s con is to argue that climate change, while a valid concern, is a much lower priority than dealing with starvation and disease in the developing world. Mashey points out, however, that buddy Bjorn is too busy enriching himself on the denier think tank speaker circuit to actually spend any time advocating for an increase in global aid.

Mashey’s more polite than I would have been, but he also shreds Lomborg and his entire argument to better effect.

Related Posts

on

Cheniere Energy has introduced “cargo emissions tags” to assuage climate concerns of potential buyers. But a new report says these tags are riddled with problems.

Cheniere Energy has introduced “cargo emissions tags” to assuage climate concerns of potential buyers. But a new report says these tags are riddled with problems.
Opinion
on

Anti-science rhetoric and special interests have pushed us to the edge of climate chaos. But just as quantum physics disrupted our view of matter and energy, quantum social change disrupts our beliefs about what’s possible, how fast, and by whom.

Anti-science rhetoric and special interests have pushed us to the edge of climate chaos. But just as quantum physics disrupted our view of matter and energy, quantum social change disrupts our beliefs about what’s possible, how fast, and by whom.
on

Climate campaigners concerned over Jane Toogood’s role in a company that sells technology to produce hydrogen from methane.

Climate campaigners concerned over Jane Toogood’s role in a company that sells technology to produce hydrogen from methane.
on

The Vermont senator nevertheless supported final passage of the Inflation Reduction Act, calling it "a step forward" on climate and drug prices.

The Vermont senator nevertheless supported final passage of the Inflation Reduction Act, calling it "a step forward" on climate and drug prices.